Cargando…

Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors

The gastrointestinal hormone ghrelin reduces energy expenditure and stimulates food intake. Ghrelin analogs are a possible treatment against cancer anorexia-cachexia syndrome (CACS). This study aimed to investigate whether oral treatment with the non-peptidergic ghrelin receptor agonist HM01 counter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villars, Fabienne O., Pietra, Claudio, Giuliano, Claudio, Lutz, Thomas A., Riediger, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454899/ https://www.ncbi.nlm.nih.gov/pubmed/28475119 http://dx.doi.org/10.3390/ijms18050986

Ejemplares similares

Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson’s Disease in Male Rats
por: Minalyan, Artem, et al.
Publicado: (2019)

Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT(3) Antagonist, Palonosetron and With the NK(1) Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)
por: Rudd, John A., et al.
Publicado: (2018)

Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects against Redox-Dependent Sarcopenia
por: Ranjit, Rojina, et al.
Publicado: (2022)

Modeling human cancer cachexia in colon 26 tumor-bearing adult mice
por: Talbert, Erin E., et al.
Publicado: (2014)

Corrigendum: Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT(3) Antagonist, Palonosetron and With the NK(1) Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)
por: Rudd, John A., et al.
Publicado: (2018)

Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma
por: Matsumoto*, T, et al.
Publicado: (1999)

A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice
por: Nakamura, Kentaro, et al.
Publicado: (2018)

Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
por: Pietra, Claudio, et al.
Publicado: (2014)

Characterization of Mice Bearing Subclones of Colon 26 Adenocarcinoma Disqualifies Interleukin‐6 as the Sole Inducer of Cachexia
por: Soda, Kuniyasu, et al.
Publicado: (1994)

Ghrelin for cachexia
por: Akamizu, Takashi, et al.
Publicado: (2010)

Effect of Sipjeondaebo-Tang on Cancer-Induced Anorexia and Cachexia in CT-26 Tumor-Bearing Mice
por: Choi, Youn Kyung, et al.
Publicado: (2014)

Increased Hepatic Nicotinamide N‐Methyltransferase Activity as a Marker of Cancer Cachexia in Mice Bearing Colon 26 Adenocarcinoma
por: Okamura, Atsushi, et al.
Publicado: (1998)

Trabectedin and Lurbinectedin Extend Survival of Mice Bearing C26 Colon Adenocarcinoma, without Affecting Tumor Growth or Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)

IL-6 is dispensable for causing cachexia in the colon carcinoma 26 model
por: Kwon, Young-Yon, et al.
Publicado: (2023)

Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
por: Fujitsuka, N, et al.
Publicado: (2011)

Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics
por: N Mohammadi, Ehsan, et al.
Publicado: (2020)

Chronic Renal Failure, Cachexia, and Ghrelin
por: Laviano, A., et al.
Publicado: (2010)

Novel mechanism of ghrelin therapy for cachexia
por: Hatanaka, Michiyoshi, et al.
Publicado: (2015)

Tumour‐derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour‐bearing mice
por: Kandarian, Susan C., et al.
Publicado: (2018)

Anorexia‐cachexia syndrome in hepatoma tumour‐bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC‐1/GDF15
por: Borner, Tito, et al.
Publicado: (2016)

Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse
por: Aulino, Paola, et al.
Publicado: (2010)

Hochuekkito (TJ-41), a Kampo Formula, Ameliorates Cachexia Induced by Colon 26 Adenocarcinoma in Mice
por: Yae, Suzu, et al.
Publicado: (2012)

Natural ghrelin in advanced cancer patients with cachexia, a case series
por: Blum, David, et al.
Publicado: (2021)

Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery
por: T. de Barros, Cecilia, et al.
Publicado: (2020)

PA01.26. Clinical application of quantum physics in ayurveda
por: Gandhi, Manaan, et al.
Publicado: (2012)

Swimming Attenuates Muscle Wasting and Mediates Multiple Signaling Pathways and Metabolites in CT-26 Bearing Mice
por: Li, Jiapeng, et al.
Publicado: (2022)

Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia
por: Murphy, Kate T., et al.
Publicado: (2012)

Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia
por: Müller, Timo D., et al.
Publicado: (2010)

Rikkunshito, a ghrelin potentiator, ameliorates anorexia–cachexia syndrome
por: Fujitsuka, Naoki, et al.
Publicado: (2014)

Plasma Ghrelin Levels Are Associated with Anorexia but Not Cachexia in Patients with NSCLC
por: Blauwhoff-Buskermolen, Susanne, et al.
Publicado: (2017)

OR26-01 A Novel Small Molecule Thyrotropin Receptor Antagonist
por: Kahaly, George Jean, et al.
Publicado: (2023)

Corrigendum: Swimming attenuates muscle wasting and mediates multiple signaling pathways and metabolites in CT-26 bearing mice
por: Li, Jiapeng, et al.
Publicado: (2022)

Identification of the novel HLA‐B*51:01:01:78 allele and confirmation of extended sequence of B*18:01:26
por: Ulrich, Silvia, et al.
Publicado: (2022)

Abstracts of the 2(nd) Cancer Cachexia Conference, Montreal, Canada, 26–28 September 2014
Publicado: (2015)

Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma–Induced Cancer Cachexia
por: Park, Jong Min, et al.
Publicado: (2021)

High-intensity eccentric training ameliorates muscle wasting in colon 26 tumor-bearing mice
por: Tatebayashi, Daisuke, et al.
Publicado: (2018)

Higher tumor mass and lower adipose mass are associated with colon-26 adenocarcinoma-induced cachexia in male, female and ovariectomized mice
por: Banh, Taylor, et al.
Publicado: (2019)

Run 260, 28.22.72. 26 GeV, Ring 1, 26 FP, Run 264, 01.12.72. 26 GeV, Ring 1, 26 FP, Desorption coefficients for hot and cold vacuum chambers
por: Calder, R, et al.
Publicado: (1972)

Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model
por: Northrup, R., et al.
Publicado: (2013)

Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia
por: Salade, Laurent, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vjqjgocqsf2ahn5v3hd477bl89